Press Releases

Annual Report 2013 Active Biotech AB (publ)
April 7, 2014 10:10 (CEST)
Annual Report 2013 Active Biotech AB (publ)
April 7, 2014 10:00 (CEST)
Change in the clinical development program for laquinimod
February 19, 2014 14:03 (CET)
Change in the clinical development program for laquinimod
February 19, 2014 14:00 (CET)
Active Biotech AB Year-end report January - December 2013
February 13, 2014 08:37 (CET)
Active Biotech AB Year-end report January - December 2013
February 13, 2014 08:30 (CET)
Teva and Active Biotech Remain Committed to the Development of NERVENTRA® (laquinimod) for Multiple Sclerosis Following the Negative Opinion from the EMA's CHMP
January 24, 2014 13:13 (CET)
Active Biotech to Present at the 32nd Annual J.P. Morgan Healthcare Conference
January 9, 2014 11:25 (CET)
Active Biotech to Present at the 32nd Annual J.P. Morgan Healthcare Conference
January 9, 2014 11:18 (CET)
Laquinimod CHMP/EMA Opinion
December 20, 2013 13:28 (CET)